Home >
News
NEWS AND PRESS
News room
March 25, 2010 | media: Press Release
Disitertide (P144), jointly developed by ISDIN and Digna Biotech showed a statistically significant improvement versus placebo in the patients that perceived improvement of the treated skin area affected by systemic sclerosis
News room
January 19, 2010
Digna Biotech starts the clinical research phase with interferon alpha-5 in patients with genotype 1 chronic hepatitis C that have not healed with previous treatment
Press releases
September 10, 2009
Biotecnol, Digna Biotech and Genentech enter into an Exclusive License and Option Agreement, for treatment of life-threatening liver diseases
News room
May 15, 2009 | media: Press Release
Cardiotrophin-1 showed to improve survival in a rabbit model of fulminant hepatic failure (FHF) of viral origin.
© Digna Biotech · Legal Information
Top